Riobell Combination Tablets LD, manufactured by Teijin Pharma, contain Alogliptin benzoate and Pioglitazone hydrochloride. This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, with a YJ code of 3969103F1024 and a standard of 1 tablet.
Riobell Combination Tablets LD
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →